[F-18]RGD-K5

N/A

Report date: 2022/11/27 23:58:57

NME

Base Information

Drug Name[F-18]RGD-K5

Drug Alias Name[F-18]RGD-K5

ClassificationSmall molecules > Heterocyclic drugs

Mechanisms of ActionPositron-emission tomography enhancers

TargetsNot applicable

Therapy Area/IndicationsCarcinoma, Non-Small-Cell LungColonic NeoplasmsBreast Neoplasms

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryN/A

CombinationsNo

Global Highest StatusPhase 2 Clinical

Highest Status in ChinaN/A

Originator CompaniesSiemens

China Registration ClassN/A

Active CompaniesSiemens

Inactive CompaniesN/A

Active IndicationsCarcinoma, Non-Small-Cell LungColonic NeoplasmsBreast Neoplasms

Inactive IndicationsN/A

ATC CodeN/A